Medication info
Glytec Tablet 2 mg (Glymepiride)

Glytec Tablet 2 mg (Glymepiride)

Prescription medicationTabletOral
Ingredient · strength
Glimepiride›2mg / 1 tablet
Manufacturer / importer
Dongkwang Pharmaceutical Co., Ltd.
Appearance
Green rectangular tablet
Packaging
90 tablets/box [(10 tablets/PTP) x 9], 30 tablets/bottle, 300 tablets/bottle
Approval status
Active

MFDS item code 200400124 · Notified 2004.03.29 · Insurance code 645900030

Summary

Main use
Improvement of glycemic control in type 2 diabetes mellitus
Who takes it
Adults
Adult dose
Adjust the dose individually for each patient. Swallow without chewing with at least 1/2 cup of water. Take this medicine orally once daily. Take this medicine before breakfast or immediately before the first meal. It is very important not to skip a meal after taking this medicine. 1. Monotherapy 1) Initial dose and dose titration For patients who have not previously received medication, initiate treatment with glimepiride 1 mg once daily. If necessary, increase the dose by 1 mg at intervals of 1 ~ 2 weeks. Generally, doses above 4 mg provide little additional effect, although some patients have achieved better metabolic control with doses increased to 6 mg (or 8 mg). If treatment with 4 mg daily is unsuccessful, first consider switching to insulin therapy; otherwise, consider combination treatment with insulin or another oral antidiabetic medicine. 2) Subsequent dose adjustment As diabetes control may improve during treatment, the amount of this medicine needed may decrease. Therefore, dose reduction or discontinuation of this medicine may be necessary to avoid hypoglycemia. Dose adjustment should also be considered if weight loss, lifestyle changes, or other factors that may increase the risk of hypoglycemia or hyperglycemia occur. 3) Switching from another oral hypoglycemic agent to this medicine There is no exact dose equivalence between this medicine and other oral hypoglycemic agents. When switching from another oral hypoglycemic agent to this medicine, it is advisable to follow the method described under Initial Dose. That is, start with 1 mg daily and adjust the dose at intervals of 1 ~ 2 weeks. Consider the potency and duration of action of the previously administered medicine. 4) Monitoring during treatment Blood glucose and/or urine glucose levels should be measured regularly while taking this medicine. Regular measurement of glycated hemoglobin (HbA1c) is also recommended. In general, hypoglycemia is promptly controlled by immediately consuming sugar. Hypoglycemia may recur even after it has been successfully treated initially during administration of a sulfonylurea. Therefore, patients should be carefully monitored. Severe hypoglycemia requires immediate medical treatment and follow-up, and hospitalization is sometimes necessary. 2. Combination therapy 1) Combination therapy with insulin Combination therapy with this medicine and insulin is used in patients with secondary failure and when fasting blood glucose (FBG) exceeds 150 mg/dL. Administer 8 mg of this medicine once daily with the first meal, and start insulin at a low dose, increasing it approximately weekly according to fasting blood glucose measurements. Once stabilized, monitor capillary blood glucose daily whenever possible. Insulin doses should be adjusted periodically while measuring blood glucose and glycated hemoglobin. 2) Combination therapy with metformin If the patient does not respond adequately to the maximum dose of this medicine, addition of metformin may be considered. Published clinical information is available on combination therapy of metformin with other sulfonylureas, such as glibenclamide, glipizide, chlorpropamide, and tolbutamide. With combination therapy of this medicine and metformin, the desired blood glucose level may be achieved by adjusting the dose of each medicine. However, efforts should be made to identify the minimum effective dose of each medicine for glycemic control. There is a risk of hypoglycemia with concomitant administration of this medicine and metformin, and the risk may increase. Appropriate precautions should be taken.

Ingredients

Manufacturer
Dongkwang Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of glycemic control in type 2 diabetes mellitus

View approved original text

This medication is used to assist in controlling blood sugar levels in patients with type 2 diabetes. It is administered as an adjunct to dietary and exercise therapy, and can also be used alone. If blood sugar control is insufficient, it may be combined with oral hypoglycemic agents or insulin. Particularly, it is used in conjunction with metformin when treatment with sulfonylureas or metformin alone is ineffective. It helps improve blood sugar control when used with various treatment methods.

How to take

Adult dose

Adjust the dose individually for each patient. Swallow without chewing with at least 1/2 cup of water. Take this medicine orally once daily. Take this medicine before breakfast or immediately before the first meal. It is very important not to skip a meal after taking this medicine. 1. Monotherapy 1) Initial dose and dose titration For patients who have not previously received medication, initiate treatment with glimepiride 1 mg once daily. If necessary, increase the dose by 1 mg at intervals of 1 ~ 2 weeks. Generally, doses above 4 mg provide little additional effect, although some patients have achieved better metabolic control with doses increased to 6 mg (or 8 mg). If treatment with 4 mg daily is unsuccessful, first consider switching to insulin therapy; otherwise, consider combination treatment with insulin or another oral antidiabetic medicine. 2) Subsequent dose adjustment As diabetes control may improve during treatment, the amount of this medicine needed may decrease. Therefore, dose reduction or discontinuation of this medicine may be necessary to avoid hypoglycemia. Dose adjustment should also be considered if weight loss, lifestyle changes, or other factors that may increase the risk of hypoglycemia or hyperglycemia occur. 3) Switching from another oral hypoglycemic agent to this medicine There is no exact dose equivalence between this medicine and other oral hypoglycemic agents. When switching from another oral hypoglycemic agent to this medicine, it is advisable to follow the method described under Initial Dose. That is, start with 1 mg daily and adjust the dose at intervals of 1 ~ 2 weeks. Consider the potency and duration of action of the previously administered medicine. 4) Monitoring during treatment Blood glucose and/or urine glucose levels should be measured regularly while taking this medicine. Regular measurement of glycated hemoglobin (HbA1c) is also recommended. In general, hypoglycemia is promptly controlled by immediately consuming sugar. Hypoglycemia may recur even after it has been successfully treated initially during administration of a sulfonylurea. Therefore, patients should be carefully monitored. Severe hypoglycemia requires immediate medical treatment and follow-up, and hospitalization is sometimes necessary. 2. Combination therapy 1) Combination therapy with insulin Combination therapy with this medicine and insulin is used in patients with secondary failure and when fasting blood glucose (FBG) exceeds 150 mg/dL. Administer 8 mg of this medicine once daily with the first meal, and start insulin at a low dose, increasing it approximately weekly according to fasting blood glucose measurements. Once stabilized, monitor capillary blood glucose daily whenever possible. Insulin doses should be adjusted periodically while measuring blood glucose and glycated hemoglobin. 2) Combination therapy with metformin If the patient does not respond adequately to the maximum dose of this medicine, addition of metformin may be considered. Published clinical information is available on combination therapy of metformin with other sulfonylureas, such as glibenclamide, glipizide, chlorpropamide, and tolbutamide. With combination therapy of this medicine and metformin, the desired blood glucose level may be achieved by adjusting the dose of each medicine. However, efforts should be made to identify the minimum effective dose of each medicine for glycemic control. There is a risk of hypoglycemia with concomitant administration of this medicine and metformin, and the risk may increase. Appropriate precautions should be taken.

Precautions

This medication should not be used in patients with insulin-dependent diabetes, diabetic ketoacidosis, or in a coma. It is also contraindicated for patients with an allergy to this medication or its components, or those with severe liver or kidney dysfunction. It is safest not to use this medication in pregnant or nursing women. Patients with severe infections, before and after surgery, or those who have experienced severe trauma are recommended to use insulin therapy and should avoid this medication. Caution is advised as gastrointestinal disturbances such as vomiting or diarrhea can lead to poor absorption of food, increasing the risk of hypoglycemia. During the first week of dosing, the risk of hypoglycemia is high, so blood sugar levels should be checked frequently and monitored closely. Particularly, elderly patients, those with poor nutritional status or irregular eating habits, patients who consume alcohol frequently, and those with weakened liver or kidney function should use this medication more cautiously. This medication can cause hypoglycemia, so patients should be well aware of hypoglycemic symptoms and should consume sugar immediately when they occur. Hypoglycemic symptoms may include headache, severe hunger, dizziness, confusion, drowsiness, decreased consciousness, etc. In severe cases, loss of consciousness or coma may occur, necessitating immediate medical assistance. This medication can have various side effects, including liver dysfunction, blood disorders, and allergic reactions; therefore, if abnormal symptoms occur, consult a physician immediately. To maintain blood sugar control, regular administration of this medication along with dietary plans, exercise therapy, and weight management is important. When taking other medications, interactions may affect blood sugar control, so be sure to inform medical personnel. Caution is necessary when taken with certain antibiotics, anticoagulants, beta-blockers, steroids, etc. Overdosing on this medication can cause severe hypoglycemia, so if overdosed, immediate hospital attention and appropriate treatment are required. The safety and efficacy of this medication have not been established in children, and dosage adjustment may be necessary in elderly patients due to decreased kidney function. Keep the medication out of reach of children and store it in its original container.

Side effects

Hypoglycemia, headache, severe hunger, nausea, vomiting, fatigue, sleep, sleep disorders, anxiety, aggression, decreased concentration, reduced agility or activity, depression, confusion, speech disorders, aphasia, visual impairment, tremors, incomplete paralysis, perceptual disturbances, dizziness, weakness, loss of self-control, temporary mental confusion, brain convulsions, drowsiness, loss of consciousness, coma, shallow breathing, bradycardia, sweating, cold and clammy skin, tachycardia, hypertension, palpitations, angina pectoris, venous arrhythmia, blurred vision, fullness or pressure in the upper abdomen, abdominal pain, diarrhea, increased liver enzymes, liver dysfunction, bile secretion disorder, jaundice, hepatitis, thrombocytopenia, leukopenia, hemolytic anemia, erythrocytopenia, agranulocytosis, pancytopenia, itching, hives, rash, shortness of breath, hypotension, shock, anaphylaxis, angioedema, Stevens-Johnson syndrome, allergic vasculitis, photosensitivity reactions of the skin, decreased serum sodium concentration, taste disturbances, hair loss, weight gain, dizziness, liver dysfunction, abdominal pain, arthralgia, dyspepsia, facial edema, erectile dysfunction, facial flushing, gastritis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent exposure to air or moisture. The recommended storage temperature is between 1°C and 30°C room temperature.

Appearance and packaging

Appearance

Green rectangular tablet

Package unit

90 tablets/box [(10 tablets/PTP) x 9], 30 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.